An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack
Public ClinicalTrials.gov record NCT00330850. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to show the efficacy of a single dose of PRO-513 for treating subjects suffering moderate pain form a migraine attack, with or without aura. The study is also intended to show the effectiveness of PRO-513 for associated symptoms of nausea, photophobia, and phonophobia due to a migraine attack.
Study identification
- NCT ID
- NCT00330850
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 650 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Dec 2006 (Type not available)
- Last update posted
- Apr 2, 2007
2006
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Associated Neurologists of Southern CT | Fairfield | Connecticut | 06824 | — |
| New England Center for Headache | Stamford | Connecticut | 06902 | — |
| LCFP Inc. | Fort Myers | Florida | 33907 | — |
| Palm Beach Neurological Center | Palm Beach Gardens | Florida | 33410 | — |
| Diamond Headache Clinic | Chicago | Illinois | 60614 | — |
| International Research Center | Towson | Maryland | 21286 | — |
| Michigan Head-Pain and Neurologic Institute | Ann Arbor | Michigan | 48104 | — |
| Mercy Health Research | St Louis | Missouri | 63141 | — |
| New York Headache Center | New York | New York | 10021 | — |
| Headache Wellness Center | Greensboro | North Carolina | 27401 | — |
| DermResearch, Inc. | Austin | Texas | 78759 | — |
| J&S Studies, Inc. | Bryan | Texas | 77802 | — |
| Houston Headache Clinic | Houston | Texas | 77004 | — |
| Road Runner Research, Ltd. | San Antonio | Texas | 78258 | — |
| The Innovative Clinical Research Center | Alexandria | Virginia | 22304 | — |
| Advanced Healthcare, S.C. | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00330850, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2007 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00330850 live on ClinicalTrials.gov.